Wedbush maintains Rocket Pharmaceuticals $15 price target
Benzinga reports Wedbush maintained its $15.00-per-share price target on Rocket Pharmaceuticals.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Wedbush maintains Rocket Pharmaceuticals PT at $15.00
Wedbush maintained its $15.00 per-share price target for Rocket Pharmaceuticals, according to Benzinga.